IMPACT OF PHARMACEUTICAL CARE ON CLINICAL AND HOLISTIC OUTCOMES AMONG SCHIZOPHRENIC PATIENTS

Phase 4

Completed

• Conditions: Pharmaceutical care; Schizophrenia , Quality of life, Medical Adherence ,Antipsychotics

• Registration Number: TCTR20230320012
• Lead Sponsor: ational Research Council of Thailand (NRCT)

Brief Summary

By providing the pharmaceutical care in schizophrenic patients, this can increase the safety use of antipsychotic drugs in the patients. Also, there is a tendency of a change in medication-taking behavior and increasing pharmaceutical therapy-related quality of life.

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-06-30
• Results First Posted: 2022-09-28
• Study Start: 2023-03-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

1.repeated inpatient treatment with antipsychotic drugs within 28 days from last hospital discharge or re-entering inpatient treatment for at least the third within a year due to risk of violence as defined by the Department of Mental Health 2) able to communicate with staff and caregivers in Thai

Exclusion Criteria

1. Persons whose doctors planned to provide electroconvulsive therapy (ECT) or who had received any form of electrical stimulation therapy and people with mental retardation. 2) patients causing violence while receiving pharmaceutical care or requiring transfer to another hospital for any reason.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
quality of life in medication 4 weeks (IPD) ,4 weeks (OPD) mean change in PROMPT-QoL score

Secondary Outcome Measures

Name	Time	Method
medication adherence 4weeks (OPD) MTB-Thai score